<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0020180"><a href="http://purl.obolibrary.org/obo/MONDO_0020180">MONDO:0020180</a></h3>
<p><strong>Label:</strong> palpebral piliary tumor</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0011512">MONDO:0011512</a> (Brooke-Spiegler syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0011114">MONDO:0011114</a> (familial multiple trichoepithelioma),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_612099">OMIM:612099</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79493">Orphanet:79493</a>, <a href="http://www.orpha.net/ORDO/Orphanet_867">Orphanet:867</a>, <a href="http://purl.obolibrary.org/obo/OMIM_132700">OMIM:132700</a>, <a href="http://purl.obolibrary.org/obo/OMIM_605041">OMIM:605041</a>, <a href="http://purl.obolibrary.org/obo/OMIM_601606">OMIM:601606</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0003581">HP:0003581</a> (Adult onset) and <a href="http://purl.obolibrary.org/obo/HP_0008069">HP:0008069</a> (Neoplasm of the skin) 45.53%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002671">HP:0002671</a> (Basal cell carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system))) 45.53%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0003581">HP:0003581</a> (Adult onset) and <a href="http://purl.obolibrary.org/obo/HP_0008069">HP:0008069</a> (Neoplasm of the skin) 45.53%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0003581">HP:0003581</a> (Adult onset) and <a href="http://purl.obolibrary.org/obo/HP_0008069">HP:0008069</a> (Neoplasm of the skin) 45.53%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002671">HP:0002671</a> (Basal cell carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000478">HP:0000478</a> (Abnormality of the eye))) 43.39%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 38.09%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000951">HP:0000951</a> (Abnormality of the skin) 36.51%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001574">HP:0001574</a> (Abnormality of the integument) 36.20%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 34.98%</li>
<li>Thing 34.97%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 34.97%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003581">HP:0003581</a> (Adult onset) 34.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008069">HP:0008069</a> (Neoplasm of the skin) 34.28%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002671">HP:0002671</a> (Basal cell carcinoma) 33.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 29.32%</li>
</ul>
</body>
</html>
